Allergan, Others Hit With Generic Drug Price-Fixing Suit

Law360, New York (April 26, 2016, 7:22 PM EDT) -- Six companies, including Allergan PLC, involved in the manufacture and distribution of generic versions of two drugs have been colluding to dramatically raise the prices of the drugs since at least 2013, according to a putative class action filed Monday in Pennsylvania federal court.

The drugmakers — which also include Impax Laboratories Inc., Mylan Pharmaceuticals Inc., Lannett Company Inc., West-Ward Pharmaceuticals Corp. and Par Pharmaceutical Companies Inc. — have pushed the price of digoxin, a heart drug, and doxycycline, an antibiotic, many times higher than what they once were, the plaintiff, Edward Carpinelli, said in his 86-page complaint.

Doxycycline — which...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!